BLOOMINGTON, Ind.--(BUSINESS WIRE)--The first ten patients have been enrolled in Cook Medical’s VIVO clinical research study. The study is designed to evaluate the safety and effectiveness of treating symptomatic iliofemoral venous outflow obstruction with the Zilver® Vena™ Venous Self-Expanding Stent. The trial’s first patients are undergoing treatment at six healthcare facilities in the East Coast and Midwest regions. Dr. Charles B. Ross, chief of vascular and endovascular services at Piedmont Heart Institute was the first physician to enroll a patient in the study.
Help employers find you! Check out all the jobs and post your resume.
